146 related articles for article (PubMed ID: 36990395)
21. Determining which patients require irradiation of the supraclavicular nodal area after surgery for N1 breast cancer.
Yu JI; Park W; Huh SJ; Choi DH; Lim YH; Ahn JS; Yang JH; Nam SJ
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1135-41. PubMed ID: 20231065
[TBL] [Abstract][Full Text] [Related]
22. Can axillary and supraclavicular radiotherapy be avoided after breast-conserving surgery and axillary dissection in women with multiple involved axillary nodes? Experience at the European Institute of Oncology.
Galimberti V; Leonardi MC; Rotmensz N; Botteri E; Iodice S; Sagona A; Sahium RC; Bassani G; Berrettini A; Monti S; Gentilini O; Sangalli C; Luini A; Orecchia R; Veronesi U
Tumori; 2008; 94(1):52-8. PubMed ID: 18468335
[TBL] [Abstract][Full Text] [Related]
23. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up.
Louis-Sylvestre C; Clough K; Asselain B; Vilcoq JR; Salmon RJ; Campana F; Fourquet A
J Clin Oncol; 2004 Jan; 22(1):97-101. PubMed ID: 14701770
[TBL] [Abstract][Full Text] [Related]
24. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
Duraker N; Demir D; Bati B; Yilmaz BD; Bati Y; Çaynak ZC; Sobutay E
Jpn J Clin Oncol; 2012 Jul; 42(7):601-8. PubMed ID: 22511807
[TBL] [Abstract][Full Text] [Related]
25. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
[No Abstract] [Full Text] [Related]
26. Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement.
Ma T; Mao Y; Wang H
Cancer Manag Res; 2020; 12():11857-11869. PubMed ID: 33239916
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of local recurrence in breast cancer after postmastectomy radiotherapy.
Dunst J; Steil B; Furch S; Fach A; Lautenschläger C; Diestelhorst A; Lampe D; Kölbl H; Richter C
Strahlenther Onkol; 2001 Oct; 177(10):504-10. PubMed ID: 11680014
[TBL] [Abstract][Full Text] [Related]
28. Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR).
Lv M; Li J; Guo H; Wang C; Tian P; Ma Y; Chen X; Luo S
Ann Surg Oncol; 2021 Sep; 28(9):5098-5109. PubMed ID: 33598861
[TBL] [Abstract][Full Text] [Related]
29. Radiation field design and regional control in sentinel lymph node-positive breast cancer patients with omission of axillary dissection.
Setton J; Cody H; Tan L; Morrow M; Hudis C; Catalano J; McCormick B; Powell S; Ho A
Cancer; 2012 Apr; 118(8):1994-2003. PubMed ID: 21882186
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
31. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
32. Treatment of the axilla in early breast cancer: past, present and future.
Chua B; Ung O; Boyages J
ANZ J Surg; 2001 Dec; 71(12):729-36. PubMed ID: 11906388
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy.
Mehta K; Haffty BG
Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):679-85. PubMed ID: 8690633
[TBL] [Abstract][Full Text] [Related]
34. Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
Sun XF; Wang YJ; Huang T; Niu LJ; Zhang Q; Liu ZZ
Gland Surg; 2020 Oct; 9(5):1513-1520. PubMed ID: 33224826
[TBL] [Abstract][Full Text] [Related]
35. Axillary and supraclavicular recurrences are rare after axillary lymph node dissection in breast cancer.
Siponen ET; Vaalavirta LA; Joensuu H; Leidenius MH
World J Surg; 2012 Feb; 36(2):295-302. PubMed ID: 22202994
[TBL] [Abstract][Full Text] [Related]
36. Limited Supraclavicular Radiation Field in Breast Cancer With ≥ 10 Positive Axillary Lymph Nodes.
Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
Clin Breast Cancer; 2016 Jun; 16(3):e15-21. PubMed ID: 26732519
[TBL] [Abstract][Full Text] [Related]
37. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
; McGale P; Taylor C; Correa C; Cutter D; Duane F; Ewertz M; Gray R; Mannu G; Peto R; Whelan T; Wang Y; Wang Z; Darby S
Lancet; 2014 Jun; 383(9935):2127-35. PubMed ID: 24656685
[TBL] [Abstract][Full Text] [Related]
38. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
Krag DN; Anderson SJ; Julian TB; Brown AM; Harlow SP; Costantino JP; Ashikaga T; Weaver DL; Mamounas EP; Jalovec LM; Frazier TG; Noyes RD; Robidoux A; Scarth HM; Wolmark N
Lancet Oncol; 2010 Oct; 11(10):927-33. PubMed ID: 20863759
[TBL] [Abstract][Full Text] [Related]
39. Benefit of post-mastectomy radiotherapy of the supra-/infraclavicular lymphatic drainage area in breast cancer patients.
He ZY; Wu SG; Zhou J; Sun JY; Li FY; Lin Q; Guo L; Lin HX
Asian Pac J Cancer Prev; 2014; 15(14):5557-63. PubMed ID: 25081664
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes.
Koca E; Kuzan TY; Dizdar O; Babacan T; Sahin I; Ararat E; Altundag K
Med Oncol; 2013; 30(3):615. PubMed ID: 23729267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
